A class-action lawsuit against MRI developers Advanced NMR and Advanced Mammography Systems has been dismissed, the Wilmington, MA, companies announced last week. The lawsuit was filed in February 1996 after Advanced NMR announced plans to merge with
A class-action lawsuit against MRI developers Advanced NMR and Advanced Mammography Systems has been dismissed, the Wilmington, MA, companies announced last week. The lawsuit was filed in February 1996 after Advanced NMR announced plans to merge with AMS, a breast MRI developer in which ANMR is a majority shareholder. Those plans were called off three months later after AMS secured a $3 million infusion of capital (SCAN 5/22/96).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.